Back to News
Market Impact: 0.18
Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
Source: Business Wire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
IDT and Aldevron launched research-grade S.p. Cas9 mRNA in wild-type and SpyFi formats for CRISPR genome-editing research and development. The product introduction expands tools available to researchers, but the announcement provides no revenue, commercial adoption, or financial guidance metrics.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- US official says upcoming spectrum auctions could generate more than $100 billion
- Investors react to Fed hike and market sell-off: Brace for 'higher for longer' rates
- AI Buildout Hits Inflation as Fed Hikes Rates
- OpenAI discloses six more instances of ’concerning’ AI model behavior
- The Competition's Response to Tesla Robotaxi Day
- Snap tries to bring AR glasses to enterprise market, partnering with Nvidia, AWS and Salesforce
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Index and ETF Holdings Data for AI Research
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)